Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of AbbVie concerning possible breaches of fiduciary duty related to allegations by the Federal Trade Commission that AbbVie filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of the testosterone replacement drug, AndroGel.
Shareholders interested in seeking to recover damages on behalf of ABBV and to implement corporate governance measures designed to prevent future misconduct should contact the firm.
If you hold ABBV shares and you would like to discuss your legal rights, please email the firm at info@hkh-lawfirm.com. You can also contact us by calling Ligaya T. Hernandez at (610) 994-0292 or by sending an e-mail to lhernandez@hkh-lawfirm.com.